Demand for Unapproved Weight Loss Drug Surges on Social Media MedPage Today In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA moves toward easing restrictions on certain peptides BioPharma Dive BPC 157: Miracle Healing Peptide or Hidden Danger? A closer look at the unapproved peptide injections promoted by influencers and celebrities king5.com